115 related articles for article (PubMed ID: 28655546)
1. Optimised NLC: a nanotechnological approach to improve the anaesthetic effect of bupivacaine.
Rodrigues da Silva GH; Ribeiro LNM; Mitsutake H; Guilherme VA; Castro SR; Poppi RJ; Breitkreitz MC; de Paula E
Int J Pharm; 2017 Aug; 529(1-2):253-263. PubMed ID: 28655546
[TBL] [Abstract][Full Text] [Related]
2. Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study.
Da Silva GHR; de Morais Ribeiro LN; Guilherme VA; de Castro SR; Breitkreitz MC; de Paula E
Curr Drug Deliv; 2018; 15(3):388-396. PubMed ID: 28745230
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the acute cytotoxic potential of bupivacaine and 50% enantiomeric excess bupivacaine (s75-r25) incorporated into microspheres in rat sciatic nerves.
Tanaka PP; Torres MF; Tenorio SB
Rev Bras Anestesiol; 2012; 62(2):223-34. PubMed ID: 22440377
[TBL] [Abstract][Full Text] [Related]
4. [Drug-delivery systems for racemic bupivacaine (S50-R50) and bupivacaine enantiomeric mixture (S75-R25): cyclodextrins complexation effects on sciatic nerve blockade in mice].
Araújo DR; Fraceto LF; Braga Ade F; Paula Ed
Rev Bras Anestesiol; 2005 Jun; 55(3):316-28. PubMed ID: 19471836
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
Yue Y; Zhao D; Yin Q
Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
[TBL] [Abstract][Full Text] [Related]
6. Injectable in situ forming nanogel: A hybrid Alginate-NLC formulation extends bupivacaine anesthetic effect.
Rodrigues da Silva GH; Geronimo G; Ribeiro LNM; Guilherme VA; de Moura LD; Bombeiro AL; Oliveira JD; Breitkreitz MC; de Paula E
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110608. PubMed ID: 32228992
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry.
Ribeiro LN; Franz-Montan M; Breitkreitz MC; Alcântara AC; Castro SR; Guilherme VA; Barbosa RM; de Paula E
Eur J Pharm Sci; 2016 Oct; 93():192-202. PubMed ID: 27543066
[TBL] [Abstract][Full Text] [Related]
8. A pre-formulation study of tetracaine loaded in optimized nanostructured lipid carriers.
Castro SR; Ribeiro LNM; Breitkreitz MC; Guilherme VA; Rodrigues da Silva GH; Mitsutake H; Alcântara ACS; Yokaichiya F; Franco MKKD; Clemens D; Kent B; Lancellotti M; de Araújo DR; de Paula E
Sci Rep; 2021 Nov; 11(1):21463. PubMed ID: 34728779
[TBL] [Abstract][Full Text] [Related]
9. Nanogels with High Loading of Anesthetic Nanocrystals for Extended Duration of Sciatic Nerve Block.
Alejo T; Uson L; Landa G; Prieto M; Yus Argón C; Garcia-Salinas S; de Miguel R; Rodríguez-Largo A; Irusta S; Sebastian V; Mendoza G; Arruebo M
ACS Appl Mater Interfaces; 2021 Apr; 13(15):17220-17235. PubMed ID: 33821601
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
[TBL] [Abstract][Full Text] [Related]
11. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
12. Extended duration local anesthetic agent in a rat paw model.
Ickowicz DE; Golovanevski L; Domb AJ; Weiniger CF
Int J Pharm; 2014 Jul; 468(1-2):152-7. PubMed ID: 24726301
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
14. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
15. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
[TBL] [Abstract][Full Text] [Related]
16. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
17. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity.
Mendes AI; Silva AC; Catita JA; Cerqueira F; Gabriel C; Lopes CM
Colloids Surf B Biointerfaces; 2013 Nov; 111():755-63. PubMed ID: 23954816
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies.
Cortesi R; Valacchi G; Muresan XM; Drechsler M; Contado C; Esposito E; Grandini A; Guerrini A; Forlani G; Sacchetti G
J Microencapsul; 2017 Feb; 34(1):63-72. PubMed ID: 28097914
[TBL] [Abstract][Full Text] [Related]
19. Potassium channel agonists modify the local anaesthetic activity of bupivacaine in mice.
Gantenbein M; Attolini L; Bruguerolle B
Can J Anaesth; 1996 Aug; 43(8):871-6. PubMed ID: 8840069
[TBL] [Abstract][Full Text] [Related]
20. [Complexation of 50% enantiomeric excess (S75-R25) bupivacaine with cyclodextrins and spinal block anesthesia in rats.].
Araujo DR; Braga Ade F; Moraes CM; Fraceto LF; Paula Ed
Rev Bras Anestesiol; 2006 Oct; 56(5):495-506. PubMed ID: 19468595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
